Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED)

Clinical trial NCT00562159 · COMPLETED

Trial details

NCT number: NCT00562159
Sponsor: ALK-Abelló A/S
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rhinoconjunctivitis Rhinitis Conjunctivitis Allergy

Start date: 2007-11-01
Primary completion: 2009-09-01
Enrollment: 439

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.